The impact of COVID-19 on the diagnosis and treatment of lung cancer
- VernacularTitle:新型冠状病毒感染对肺癌患者诊疗的影响
- Author:
Yuqi MENG
1
;
Bin LI
1
Author Information
1. Department of Thoracic Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, P. R. China
- Publication Type:Journal Article
- Keywords:
Coronavirus disease 2019;
lung cancer;
screening;
surgical therapy;
chemotherapy;
targeted therapy;
immunotherapy;
radiotherapy
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2023;30(04):635-640
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is a complex disease with its own challenges, and is considered to be one of the most common causes of cancer death worldwide. The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has exacerbated these challenges. The aim of this review is to explore the impact of the COVID-19 pandemic on the screening, diagnosis and treatment of lung cancer. We hope to provide some experience and help for the whole process management of lung cancer patients.
